Shrewsbury woman living with incurable cancer calls for better education around disease after 'consultant had to google' what it was
Rachel Wood says if she had been diagnosed with neuroendocrine cancer earlier, it may have been caught before it became incurable
A woman from Shrewsbury is calling for more awareness and education around a rare type of cancer after hers was incurable by the time she was diagnosed.
Rachel Wood is living with neuroendocrine cancer but, when she was diagnosed after 18 months of tests and scans, she says she faced a healthcare system that knew nothing about her illness.
"As I went through the door with my consultant to get the diagnosis, he had received the diagnosis moments before I arrived at the consultation and was literally Googling 'neuroendocrine cancer' to find out what it was," she said.
The 55-year-old said she first went to her GP seven years ago with what she described as "really bad heartburn", something that wasn't considered to be anything as serious as a sign of cancer.
It wouldn't be until five years later when a tumour was picked up on her liver accidentally during a scan for an unrelated injury that doctors began questioning what was really going on.
"Nobody knew for 18 months after that scan what that tumour actually was," she said.
"I had two MRI scans, two PET scans, I gave vials of blood, but it's sneaky and it didn't show the usual markers for cancer.
"The consultant just didn't understand what was wrong with me and, because so many clinicians have never heard of neuroendocrine cancer, he didn't have it on his radar to even consider that that's what it could be."
Even after her eventual diagnosis and finding out the cancer has metastasised, Rachel's barriers didn't end there.
She said: "Once I had that cancer diagnosis, I honestly thought that the NHS would go, right, okay, so this is what happens now.
"It was anything but.
"It took months of me doing the Googling to find the specialists to then give those names to my team at the local hospital.
"I was actually composing the emails, they were sending them off, nothing was coming back, so I ended up phoning the specialists, fighting to get myself onto their lists - that is quite frankly, bonkers!
"Not only did it take so long to get a diagnosis, but you then don't even have the treatment at first when you get it.
"That was when I felt my most vulnerable and my most stressed."
She believes that had her doctors been educated about neuroendocrine cancer, she could have been diagnosed sooner, and her condition may not be incurable.
Rachel made it clear she does not blame any of the healthcare professionals involved in her care individually, but rather the system as a whole for no one being able to recognise the signs and or know what to do.
"It's simply that the consultant hadn't had the training," she said
"It wasn't part of the syllabus in the training and so, if he doesn't know about it, it's not really his fault.
"It's the wider problem in terms of the lack of training for clinicians in neuroendocrine cancer."
The national charity Neuroendocrine Cancer UK said Rachel's experience is all too common with patients with this type of cancer.
They're warning that delays limit treatment options and have launched a new report this week which estimates on average, people in the UK wait almost half a decade (4.7 years) to be diagnosed with neuroendocrine cancer.
Lisa Walker, CEO of Neuroendocrine Cancer UK, says: “People with neuroendocrine cancer are still waiting, on average, almost five years for the correct diagnosis. That is far too long.
"Patients should not have to wait years for their cancer to be recognised, navigate disconnected services or repeatedly explain their history to different professionals."
The charity said the cancer can be difficult to recognise because symptoms vary and mimic other conditions like menopause, anxiety, IBS and asthma, adding that clinicians need "guidance, support and access to specialist expertise" to help with diagnoses.
It said approximately 6,000 people are diagnosed with it in the UK every year.
Rachel is now an ambassador for the charity herself and is heavily involved in their work to raise awareness of the disease and lobby the government and NHS to do something to improve the education around it.
She said while the specialist treatment she is receiving is great, there should not have been so many delays and barriers to access it.
"At a time when you are at your most frightened, your most vulnerable, you should be able to be taken care of rather than doing it yourself, and that's not really too big an ask," Rachel said.
"I don't want to scare people, and the chances are for most, it will be ruled out, but it's better to it that way and rule it out.
"Really my greatest wish is that people know the name of the disease so they can ask the question, 'could it be neuroendocrine cancer?'."
In response, an NHS spokesperson said: “The NHS is committed to improving the recognition of less common cancers, including neuroendocrine cancer, at an earlier stage by healthcare professionals – including through the more widespread adoption of AI-driven clinical decision tools.
"The rollout of Jess’s Rule also means that GPs should reconsider a patient’s diagnosis when they arrange a third appointment with similar symptoms, including considering the possibility of cancer.”
The Department for Health and Social Care was also contacted for comment.